Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 101-111, 2004. First published November 18, 2003; 10.1373/clinchem.2003.021568
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2003.021568v1
50/1/101    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carchon, H. A.
Right arrow Articles by Jaeken, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carchon, H. A.
Right arrow Articles by Jaeken, J.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Proteomics and Protein Markers
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2004;50:101-111.)
© 2004 American Association for Clinical Chemistry, Inc.

Molecular Diagnostics and Genetics

Diagnosis of Congenital Disorders of Glycosylation by Capillary Zone Electrophoresis of Serum Transferrin

Hubert A. Carchon1,a, Roland Chevigné2, Jean-Bernard Falmagne2 and Jaak Jaeken1

1 Department of Pediatrics, Center for Metabolic Disease, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium.
2 Analis SA, Rue Dewez 14, B-5000 Namur, Belgium.

aAddress correspondence to this author at: Center for Metabolic Disease, University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. Fax 32-16-34-72-84; e-mail hubert.carchon{at}med.kuleuven.ac.be.


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Background: Congenital disorders of glycosylation (CDG) are usually diagnosed by isoelectric focusing (IEF) of serum transferrin (Tf). The aim of this study was to evaluate capillary zone electrophoresis (CZE) as a diagnostic alternative to IEF.

Methods: We performed 792 CZE analyses of Tf, using the CEofixTM-CDT (carbohydrate-deficient transferrin) assay. Peak identification was based on relative migration times (RMTs) to reduce migration variability.

Results: Tf profiles comprised three main groups (A–C). Groups A and B were characterized by one or two dominant tetrasialo-Tf peaks, whereas group C showed a widely variable Tf isoform composition. Group A was composed of four subgroups: a major group with a typical Tf profile (considered as reference group), two minor groups with decreased or moderately increased trisialo-Tf isoform, and a group showing the presence of unknown compounds with RMTs similar to mono- and disialo-Tf. However, these compounds were absent on IEF. Group C contained all profiles from patients with confirmed as well as putative CDG. From the reference group, 99% confidence intervals were calculated for the RMTs of the Tf isoforms, and percentiles representing the Tf isoform distributions were defined.

Conclusions: All patients with abnormal IEF results and confirmed CDG were identified by CZE; thus, this method can be used as a diagnostic alternative to IEF in a manner suitable for automation. Because whole serum is analyzed, it should be kept in mind that CZE profiles can show substances other than Tf.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Congenital disorders of glycosylation (CDG) 1 syndromes are a rapidly growing group of genetic diseases characterized by defects in the synthesis of the glycan moieties of glycoconjugates (1)(2)(3). The discovery of these diseases was based on the observation by Jaeken et al. (4) of unusual serum protein abnormalities in two princeps patients, namely, decreased serum thyroxine-binding globulin and increased arylsulfatase A activity. The search for a defect common to these and other proteins finally pointed to the glycan moiety because sialic acid deficiency of serum transferrin (Tf) was strongly suggested by cathodal shift of the sialotransferrins on isoelectric focusing (IEF) (5). IEF of Tf remains the cornerstone of the diagnosis of these diseases, although IEF of other proteins, such as serum {alpha}1-antitrypsin (6), has been used. IEF, however, is a labor-intensive and time-consuming technique not suitable for automation.

In 1986, Stibler et al. (7) reported a relationship between carbohydrate-deficient transferrin (CDT) in serum and chronic alcohol consumption. In the search for a suitable clinical diagnostic test for alcohol abuse, several analytical procedures, such as IEF (8), IEF in combination with immunofixation(9), zone immunoelectrophoresis (10), Western blotting (11), anion-exchange chromatography(7), and chromatofocusing (12), have been used. The problems encountered in CDT analyses using capillary zone electrophoresis (CZE) (8)(13)(14) were later resolved by an improved CZE method requiring only iron saturation as sample pretreatment (15)(16)(17) and the use of dynamically coated capillaries (18). The CEofixTM-CDT assay (Analis) is the first commercial buffer system combining the advantages of dynamic coating with simplicity of sample pretreatment and analysis (19)(20)(21)(22).

The present study aimed to evaluate CZE as an analytical tool for CDG diagnosis. The results obtained from 792 profiles indicate that CZE can be used as a diagnostic technique. However, if profiles contain unexpected peaks, CZE analysis with immunosubtraction and/or Tf IEF with immunoprecipitation should be performed.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
participants
In the last decade, >7300 IEF analyses of serum Tf have been performed in our laboratory. The majority of these samples (98%) were from patients for whom a Tf IEF analysis had been requested as a diagnostic tool for CDG. The clinical spectrum and biochemical features of CDG have been reviewed extensively by Jaeken et al. (1). The remaining 2% of the samples were from some of the parents of these patients. Chronic alcoholism was excluded in all individuals by the referring physicians. Serum samples from referring centers were transported on dry ice. In-house blood samples were collected in evacuated serum tubes, centrifuged on arrival, and stored at -20 °C until IEF or CZE analysis was performed.

For the present study, 792 samples were analyzed by CZE. A total of 743 samples (426 from males, 317 from females) were obtained from the patients and 49 (22 from males, 27 from females) were from the parents of some of the patients (Table 1 ).


View this table:
[in this window]
[in a new window]
  		Table 1. Composition with respect to age and sex in the different subgroups.

reagents
Phenylalanine (SA) and N-benzoyl-glycyl-histidyl-leucine (SB) were obtained from Sigma. Anti-human Tf was purchased from Dako. Agarose-IEF, Ampholine pH 5–7, GelBond film for agarose, and Coomassie Brilliant Blue R250 were obtained from Amersham Biosciences AB. All reagents used were of analytical grade.

ief analysis of TF
In the present method, based on the method of van Eijk et al. (23), 22 mg of agarose was suspended in 2.2 mL of cold water; the mixture was then heated until all of the agarose was dissolved and cooled to 73 °C. After the addition of 110 µL of Ampholine, the mixture was poured onto GelBond for agarose, left for 15 min at room temperature, and stored in the refrigerator overnight. The Tf sample consisted of 15 µL of serum, 70 µL of a solution containing 9 g/L NaCl, and 15 µL of 10 mmol/L Fe(III) citrate. Serum Tfs were separated on an Amersham Biosciences PhastSystem. After electrophoresis, gels were covered with undiluted antiserum (25 µL/cm2) for 30 min and kept overnight in saline. Gels were then washed with water, placed between paper layers under gentle pressure for 30 min, air dried, stained with Coomassie Brilliant Blue R250, and destained.

cze analysis of TF
CZE analyses were performed in uncoated fused-silica capillaries (50-µm i.d.; effective length, 50 cm) on a Beckman Coulter P/ACE 5000 system equipped with a single-wavelength ultraviolet absorbance detector and an interference filter at 214 nm. The buffer system and separation procedure of the CEofix-CDT assay (Analis) were used. Before each analysis, equal volumes of serum sample and iron solution (supplied with the assay reagents) were mixed and centrifuged for 1 min at 13 000g. The capillary was rinsed sequentially under pressure with a polycation-containing buffer (initiator) and a separation buffer containing a polyanion for 1.5 min and 2 min, respectively. An external standard solution (5 mmol/L SA and 2.5 mmol/L SB in 0.2 mol/L Tris-HCl buffer, pH 8.5), water, the pretreated serum sample, and again water were then injected under pressure for 3, 1, 7, and 1 s, respectively. Separation proceeded for 9 min at a constant voltage of 28 kV. Finally, the capillary was rinsed with 0.2 mol/L NaOH for 1.5 min, followed by a rinse under pressure at constant current (100 µA) for 1 min. Corrected peak areas were calculated by the Beckman integration software.

reference group
Samples obtained from patients (n = 534) and parents (n = 41) formed a reference group because of their normal IEF and CZE profiles (20). This group should not be considered as a "normal" group.

data management and evaluation
Microsoft® Visual C++, Ver. 6.0, was used to build appropriate software for data management. Data representing CZE electropherograms, migration times, and corrected peak areas were obtained from the Beckman software. The threshold and minimum peak width for integration were set at 0.01. A minimum area of 125 was used for peak acceptance. This value corresponded to 0.05% of the mean total Tf area.

Because migration times in CZE are often subject to variability, two external standards (SA and SB) were selected so that their electrophoretic mobilities sandwiched the electrophoretic mobilities of the Tf isoforms. The corresponding migration times (MTs) were used to calculate relative migration times (RMTs). Two types, indicated as RMTA and RMTB, are proposed dependent on whether a contribution of the protein has to be taken into account. The RMTA of compound X (RMTA.X) is defined as:

(1)
MTX, MTSA, and MTSB represent the migration times of compounds X, SA, and SB. Tf isoforms therefore all have a RMTA value in the range 0–1. The RMTB of compound X (RMTB.X) is defined as:

(2)
MTX and MT4 represent the migration times of compounds X and tetrasialo-Tf.

Eq. 1Up eliminates only experimental variation, whereas Eq. 2Up also eliminates variation resulting from the protein core.

statistics
The level of significance was set at 0.01. A single-factor ANOVA was used for comparing mean RMTB values of groups differing in age or sex.

We used n x 2 contingency tables to evaluate whether the frequency of 0 area values for monosialo-Tf were biased by the total Tf concentration or whether the distribution of the asialo-Tf isoform with age in group A was uniform, respectively.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
TF isoform variation
Despite the use of dynamically coated capillaries, migration times may still vary considerably over a longer period of time and after a large number of analyses. Fig. 1A shows the frequency distribution of all peaks detected within the 5–8 min time interval in the electropherograms of the reference group. This frequency distribution, however, does not reflect a normal Tf isoform profile (20). In panels B and C of Fig. 1 , the migration times of the same peaks are expressed as RMTA and RMTB, respectively. RMTA values reduce the frequency distribution to a simpler pattern in which the experimental variability (Fig. 1B ) is eliminated, whereas RMTB values in addition eliminate the variation originating from Tf polymorphisms (Fig. 1C ).



View larger version (17K):
[in this window]
[in a new window]
  		Figure 1. Frequency distribution of all peaks detected in the reference group (n = 575) within a 5–8 min time interval.

(A), real migration times; (B), RMTA values with respect to the external standards SA and SB. (C), RMTB values with respect to the tetrasialo-Tf isoform.

All CZE profiles could be assigned to three main groups with several subgroups. Figs. 2 and 3 show several types of CZE profiles and their corresponding IEF patterns. In group A (Fig. 2 ), characterized by a single tetrasialo-Tf peak, A1 represents the reference group with a "typical" Tf profile and shows the references SA and SB. In group A, trisialo-Tf had the highest variability. Therefore, two more subgroups were defined: A2, with trisialo-Tf less than disialo-Tf; and A3, with trisialo-Tf greater than pentasialo-Tf but <15% of the total Tf amount. In A4, small compounds were located at the site of mono- or disialo-Tf but are absent on IEF. In group B, two tetrasialo-Tf peaks were present, corresponding to genetic variants of Tf (24). In group C (Fig. 3 ), subgroups C1–C3 represent the profiles obtained from CDG patients. C1 comprises profiles from CDG-Ia and other CDG-I patients, whereas C2 combines all profiles but one from CDG-II patients. C3 contains a single patient with CDG-IIa (25). Subgroups C4 and C5 combine patients with unexplained CDG. In subgroup C4, trisialo-Tf is high (18–47% of the total Tf area), and C5 combines heterogeneous Tf profiles, one of which is shown.



View larger version (22K):
[in this window]
[in a new window]
  		Figure 2. CZE and IEF profiles of serum transferrin.

In group A (a single tetrasialo-Tf peak), subgroup A1 represents the reference group with a normal Tf profile, including the external standards SA and SB; in subgroup A2, the concentration of trisialo-Tf is less than that of disialo-Tf; in subgroup A3, the concentration of trisialo-Tf is greater than that of pentasialo-Tf, but trisialo-Tf accounts for <15% of total Tf. In subgroup A4, compounds are located at the site of mono- or disialo-Tf but are absent on IEF. In group B, two tetrasialo-Tf peaks are present, representing normal profiles for Tf protein variants.



View larger version (22K):
[in this window]
[in a new window]
  		Figure 3. CZE and IEF profiles of serum Tf.

Groups C1–C3 represent profiles for patients with confirmed CDG-I, CDG-II, and CDG-IIa, respectively. In group C4, trisialo-Tf is highly increased, whereas group C5 contains samples with heterogeneous Tf profiles. CZE and IEF profiles are in accordance.

TF isoform identification
As shown in Fig. 1CUp , Tf isoforms can be identified by their RMTB because of the small dispersion. Although the group was heterogeneous in terms of age and sex (Table 1Up ), there was no statistical difference between sexes, not only within each age group but also between the age groups. The entire group was therefore used to calculate the mean RMTB value and corresponding SD (Table 2 ). From these data, 99% confidence intervals were calculated and used for Tf isoform identification (Fig. 4 ). The algorithm describing the identification procedure was verified by comparing the result with the corresponding IEF pattern.


View this table:
[in this window]
[in a new window]
  		Table 2. RMTs of Tf isoforms with respect to values obtained for tetrasialo-Tf in the reference group.



View larger version (31K):
[in this window]
[in a new window]
  		Figure 4. Frequency distributions of the RMTB values of all separated compounds in the separate subgroups, superposed on the 99% confidence intervals (vertical bars) that were obtained for the RMTB values of the Tf isoforms from reference group A1.

TF isoform distribution
The relative concentration of a particular Tf isoform in the reference group was expressed as a percentage of the total Tf area. Asialo-Tf was not taken into account. The monosialo-Tf isoform was not biased by the total amount of Tf present in the sample. Table 3 summarizes the most common percentiles.


View this table:
[in this window]
[in a new window]
  		Table 3. Percentile values representing the Tf isoform distribution of the reference group (n = 575).1

According to Arndt (26) and under physiologic conditions, asialo-Tf is present at concentrations <0.5% of the total Tf. This conclusion, applied to the data for group A, gave the values shown in Table 4 . Statistically, the frequency of asialo-Tf was not evenly distributed as a function of age.


View this table:
[in this window]
[in a new window]
  		Table 4. Frequency and range of asialo-Tf as a function of age for Tf profiles showing a single tetrasialo-Tf isoform.


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
The aim of this work was to investigate whether CZE of serum Tf isoforms would be a valuable alternative to the labor-intensive and time-consuming IEF for screening of CDG. CZE of serum Tf has been used for the diagnosis of chronic alcoholism (19)(20)(22)(27)(28) but much less in CDG (13)(29). We performed a serum transferrin CZE separation on 792 samples, using the commercial CEofix-CDT assay as recommended by the manufacturer. The modification of the test procedure suggested by Legros et al. (20) was not applied because the majority of the analyses had been performed before the publication of that report. We mainly investigated three aspects: the visual appearance of the electropherogram, the identification of the separated sialotransferrins, and their distribution.

Although the variability of migration times in CZE may be largely reduced by the use of dynamically coated capillaries (30), variability remains significant over a longer period of time and after a large number of analyses (Fig. 1AUp ). Consequently, the use of real times in CZE is not appropriate. Fig. 5 shows the IEF and CZE profiles of two CDG patients, A and B, with unknown types of CDG. In the IEF profiles, lanes 1, 2, 3, and 4 represent the normal IEF pattern of four different reference individuals, whereas lanes A and B represent the patterns of the corresponding patients. Both CZE Tf profiles look rather similar, the three main Tf isoforms differing only in absorbance. In CZE profile A, the migration times are 5.35, 6.01, 6.14, 6.27, and 7.86 min for peaks SA, A1, A2, A3, and SB, respectively. In CZE profile B, the migration times are 5.20, 5.99, 6.12, 6.23, and 7.67 min for peaks SA, B1, B2, B3, and SB. The RMTA values for A1, A2, A3, B1, B2, and B3 are 0.26, 0.31, 0.37, 0.32, 0.37, and 0.42, respectively. Peaks A2 and A3 match most likely with peaks B1 and B2, which is in agreement with the IEF patterns.



View larger version (17K):
[in this window]
[in a new window]
  		Figure 5. IEF and CZE profiles of two patients, A and B, with an unknown type of CDG.

Lanes 1–4 show the IEF patterns of four different normal profiles (reference group); lanes A and B represent the patients. Real migration times of Tf peaks A1, A2, and A3 match those of peaks B1, B2, and B3. However, in agreement with the IEF profiles, RMTA values indicate a best match of A2 and A3 with B1 and B2.

RMTA values make the Tf profile independent of experimental variation such as length of the capillary or applied voltage, but the impact of the protein core remains unaffected. Fig. 6 shows the IEF and CZE profiles of two patients, A and B, and the mother (M) of patient A. The IEF and CZE profiles indicate that patient A and her mother have the same Tf protein variants.



View larger version (29K):
[in this window]
[in a new window]
  		Figure 6. IEF and CZE profiles of three individuals (A, B, and M, with M being the mother of A) showing Tf protein variants.

Individuals A and M have the same type of protein variant but differ from individual B. CZE profiles using RMTA values are in agreement with the IEF patterns.

In the present study, group A comprised all individuals with Tf profiles showing a single tetrasialo-Tf isoform. Most of these profiles would be classified as normal on IEF. However, the variability of trisialo-Tf justifies the individualization of subgroups A2 and A3. At present the reason for this variability is not clear.

The frequency of asialo-Tf in the subgroups of group A as a function of age is shown in Table 4Up . According to Arndt (26), asialo-Tf is present at concentrations <0.5% of total Tf under physiologic conditions. The frequency observed in children under 1 year of age was significantly higher than in the older patients and in the parents. This is obviously not caused by increased alcohol intake. Both parents (one mother and one father) were healthy persons, and for the remaining five patients, the referring physicians reported no indications regarding alcohol intake.

An apparent increase in a-, mono-, and disialo-Tf observed by IEF may be less pronounced in CZE. In our opinion this may be a combined effect of sample amount and the detection system. In our IEF procedure, 0.2 µL of serum is applied on the gel, whereas in CZE this is ~1 nL. Densitometry of the higher Tf isoforms may therefore be out of the linear range of the method, enhancing the importance of the smaller Tf isoform fractions.

As shown in Fig. 1CUp , the CZE method separates the Tf isoforms. Using the mean and SD (Table 2Up ), we could calculate a confidence interval for each Tf isoform by which that isoform could be identified in the electropherogram. As shown in Fig. 4Up , the 99% confidence intervals calculated for the Tf isoform in the reference group and the frequency distributions of the Tf isoform for different subgroups were superposed. It is remarkable that the RMTB values of penta- and hexasialo-Tf remain constant regardless of the changes of the profile in the lower Tf isoforms. For several patients in subgroup C1, trisialo-Tf was outside the reference interval, whereas for the others, as well as for the patients in subgroups C2 and C4, trisialo-Tf was located near the upper limit of the interval. Likewise, RMTB values for a- and monosialo-Tf in subgroup C1 seemed to be different from the corresponding values for subgroup C2. In our opinion, this is the limit of information that CZE can provide, and further investigation will require other techniques, such as glycan analysis.

A combination of "peak location" (Table 2Up ) and "peak distribution" (Table 3Up ) can be used for data reporting. Fig. 7 shows a combined presentation of Tf profile, Tf isoform identification, and distribution. Lines located within (horizontal arrows) the confidence intervals (upright bars) are identified Tf isoforms. Lines located outside the confidence intervals (vertical arrows) are unidentified peaks in the electropherogram. The line height may visualize either the percentile value obtained from the appropriate reference group or the peak area (percentage) with respect to the total Tf area, regardless of whether the Tf isoform had been identified. The numeric values in the upper horizontal bar represent the percentiles of the Tf isoforms under consideration. The values in the lower horizontal bar indicate the peak areas (percentage) of the unknown compounds with respect to the total Tf area.



View larger version (56K):
[in this window]
[in a new window]
  		Figure 7. Schematic presentation of CZE analyses and reporting.

Lines located within (horizontal arrow) the confidence intervals (vertical bars) are identified Tf isoforms. The line height equals the percentile value given at the top of the figure. Lines located outside (vertical arrow) the confidence intervals are unknown compounds. Line heights and the values at the bottom of the figure are the peak area (percentage) with respect to the total Tf area.

It must be kept in mind that full serum is used and that other compounds (endogenous or exogenous) can be detected in the Tf region. As seen in subgroup A4, we regularly observed small compounds located at the positions of mono- and disialo-Tf in CZE that were absent on IEF. Fig. 8 shows the IEF and CZE profiles of two patients with CDG-Ia (A and B) and a normal adult (M; mother of A). Profiles A and B were very similar, although the profile for patient A showed an additional peak (arrow) that was also present in the serum of the mother but absent on IEF. In a separate analysis, anti-human Tf was post-injected with the serum Tfs (profiles D and E from individuals A and M, respectively), and immunosubtraction was performed (20). The additional peak remained in both profiles, indicating that the corresponding compound was not Tf. Therefore, and we consider this as an important rule, if the Tf isoform profile of a patient shows abnormal compounds in the Tf region, serum from the parents should also be investigated and an additional separation in the presence of anti-human Tf should be performed. Alternatively, IEF can be used.



View larger version (71K):
[in this window]
[in a new window]
  		Figure 8. IEF and CZE profiles of two patients with CDG-Ia (A and B) and a normal adult (M, mother of A).

In contrast to the IEF pattern, CZE profiles A and M show an additional peak (arrow) that is not present in CZE profile B. Separately, anti-human Tf was post-injected and showed that the unknown compound remained in CZE profiles D (patient A) and E (individual M).

As shown in Figs. 2Up and 3Up , in CDG, a huge variability exists in Tf profiles. The Tf isoforms of interest for CDG are a-, mono-, di-, and trisialo-Tf, and they may all increase to a variable extent at the expense of tetrasialo-Tf. The relative concentrations of penta- and hexasialo-Tf remain remarkably constant. The values in Table 5 also reflect the variability of the distribution of these Tf isoforms. The maximum relative concentrations observed for a-, mono-, di-, and trisialo-Tf were 46.6%, 8.2%, 58.5%, and 50.6%, whereas the minimum relative concentration for tetrasialo-Tf was 10.2%.


View this table:
[in this window]
[in a new window]
  		Table 5. Percentile values representing the Tf isoform distribution for the group of CDG patients (n = 76).

In summary, because all patients with confirmed CDG could be identified, CZE of serum Tf can be used as a diagnostic technique for the detection of CDG. In our experience, ~95% of the samples analyzed for serum Tf have a normal profile. CZE analysis with immunosubtraction, Tf IEF with immunoprecipitation, or glycan analysis should be performed only for the remaining 5%, if necessary. In addition, the possibility of automation may enable much more intensive screening for the known and the many unknown glycosylation disorders that await identification.


   Acknowledgments
 
The present work was supported by the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (Grant G.0305.98N). We thank Els Jansen for skillful technical assistance.


   Footnotes
 
Previously published online at DOI: 10.1373/clinchem.2003.021568

1 Nonstandard abbreviations: CDG, congenital disorders of glycosylation; Tf, transferrin; IEF, isoelectric focusing; CDT, carbohydrate-deficient transferrin; CZE, capillary zone electrophoresis; SA, phenylalanine; SB, N-benzoyl-glycyl-histidyl-leucine; and RMT, relative migration time.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Jaeken J, Matthijs G, Carchon H, Van Schaftingen E. Defects of N-glycan synthesis. Scriver CR Beaudet AL Sly WS Valle D eds. The metabolic and molecular bases of inherited disease, 8th ed 2001:1601-1622 McGraw-Hill New York. .
  2. Jaeken J, Matthijs G. Congenital disorders of glycosylation. Annu Rev Genomics Hum Genet 2001;2:129-151.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  3. Grünewald S, Matthijs G, Jaeken J. Congenital disorders of glycosylation: a review. Pediatr Res 2002;52:618-624.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  4. Jaeken J, Vanderschueren-Lodeweyckx M, Casaer P, Snoeck L, Corbeel L, Eggermont E, et al. Familial psychomotor retardation with markedly fluctuating serum proteins, FSH and GH levels, partial TBG-deficiency, increased serum arylsulphatase A and increased CSF protein: a new syndrome?. Pediatr Res 1980;14:179.
  5. Jaeken J, van Eijk HG, van der Heul C, Corbeel L, Eeckels R, Eggermont E. Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome. Clin Chim Acta 1984;144:245-247.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  6. Krasnewich DM, Holt GD, Brantly M, Skovby F, Redwine J, Gahl WA. Abnormal synthesis of dolichol-linked oligosaccharides in carbohydrate-deficient glycoprotein syndrome. Glycobiology 1995;5:503-510.[Abstract/Free Full Text]
  7. Stibler H, Borg S, Joustra M. Micro anion exchange chromatography of carbohydrate-deficient transferrin in serum in relation to alcohol consumption (Swedish patent 8400587-5). Alcohol Clin Exp Res 1986;10:535-544.[ISI][Medline] [Order article via Infotrieve]
  8. Stibler H, Kjellin KG. Isoelectric focusing and electrophoresis of the CSF proteins in tremor of different origins. J Neurol Sci 1976;30:269-285.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  9. Schellenberg F, Weill J. Serum disialotransferrin in the detection of alcohol abuse. Alcohol Alcohol Suppl 1987;1:624-629.
  10. Chan AW, Leong FW, Schanley DL, Welte JW, Wieczorek W, Rej R, et al. Transferrin and mitochondrial aspartate aminotransferase in young adult alcoholics. Drug Alcohol Depend 1989;23:13-18.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  11. Xin Y, Lasker JM, Rosman AS, Lieber CS. Isoelectric focusing/Western blotting: a novel and practical method for quantitation of carbohydrate-deficient transferrin in alcoholics. Alcohol Clin Exp Res 1991;15:814-821.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  12. Storey EL, Mack U, Powell LW, Halliday JW. Use of chromatofocusing to detect a transferrin variant in serum of alcoholic subjects. Clin Chem 1985;31:1543-1545.[Abstract/Free Full Text]
  13. Oda RP, Prasad R, Stout RL, Coffin D, Patton WP, Kraft DL, et al. Capillary electrophoresis-based separation of transferrin sialoforms in patients with carbohydrate-deficient glycoprotein syndrome. Electrophoresis 1997;18:1819-1826.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  14. Prasad R, Stout RL, Coffin D, Smith J. Analyses of carbohydrate deficient transferrin by capillary zone electrophoresis. Electrophoresis 1997;18:1814-1818.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  15. Tagliaro F, Crivellente F, Manetto G, Puppi I, Deyl Z, Marigo M. Optimized determination of carbohydrate-deficient transferrin isoforms in serum by capillary zone electrophoresis. Electrophoresis 1998;19:3033-3039.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  16. Crivellente F, Fracasso G, Valentini R, Manetto G, Riviera AP, Tagliaro F. Improved method for carbohydrate-deficient transferrin determination in human serum by capillary zone electrophoresis. J Chromatogr B 2000;739:81-93.
  17. Trout AL, Prasad R, Coffin D, DiMartini A, Lane T, Blessum C, et al. Direct capillary electrophoretic detection of carbohydrate-deficient transferrin in neat serum. Electrophoresis 2000;21:2376-2383.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  18. Giordano BC, Muza M, Trout A, Landers JP. Dynamically-coated capillaries allow for capillary electrophoretic resolution of transferrin sialoforms via direct analysis of human serum. J Chromatogr B 2000;742:79-89.
  19. Wuyts B, Delanghe JR, Kasvosve I, Wauters A, Neels H, Janssens J. Determination of carbohydrate-deficient transferrin using capillary zone electrophoresis. Clin Chem 2001;47:247-255.[Abstract/Free Full Text]
  20. Legros FJ, Nuyens V, Minet E, Emonts P, Boudjeltia KZ, Courbe A, et al. Carbohydrate-deficient transferrin isoforms measured by capillary zone electrophoresis for detection of alcohol abuse. Clin Chem 2002;48:2177-2186.[Abstract/Free Full Text]
  21. Lanz C, Kuhn M, Bortolotti F, Tagliaro F, Thormann W. Evaluation and optimization of capillary zone electrophoresis with different capillary coatings for the determination of carbohydrate-deficient transferrin in human serum. J Chromatogr A 2002;979:43-57.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  22. Legros FJ, Nuyens V, Baudoux M, Boudjeltia KZ, Ruelle J-L, Colicis J, et al. Use of capillary zone electrophoresis for differentiating excessive from moderate alcohol consumption. Clin Chem 2003;49:440-449.[Abstract/Free Full Text]
  23. van Eijk HG, van Noort WL, Dubelaar M-L, van der Heul C. The microheterogeneity of human transferrins in biological fluids. Clin Chim Acta 1983;132:167-171.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  24. de l’Escaille F, Pourignaux F, Brohet M. Quantifying carbohydrate-deficient transferrin (CDT) in serum. P/ACE Setter 2002;6:10-12.
  25. Jaeken J, Schachter H, Carchon H, De Cock P, Coddeville B, Spik G. Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localized N-acetyl-glucosaminyltransferase II. Arch Dis Child 1994;71:123-127.[Abstract]
  26. Arndt T. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse. A critical review of preanalysis, analysis, and interpretation. Clin Chem 2001;47:13-27.[Abstract/Free Full Text]
  27. Whitfield JB. Transferrin isoform analysis for the diagnosis and management of hazardous or dependent drinking. Clin Chem 2002;48:2095-2096.[Free Full Text]
  28. Thormann W, Lurie IS, McCord B, Marti U, Cenni B, Malik N. Advances of capillary electrophoresis in clinical and forensic analysis (1999–2000). Electrophoresis 2001;22:4216-4243.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  29. Iourin O, Mattu TS, Mian N, Keir G, Winchester B, Dwek RA, et al. The identification of abnormal glycoforms of serum transferrin in carbohydrate deficient glycoprotein syndrome type I by capillary zone electrophoresis. Glycoconjugate J 1996;13:1031-1042.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  30. Righetti PG, Gelfi C, Verzola B, Castelletti L. The state of art of dynamic coatings. Electrophoresis 2001;22:603-611.[CrossRef][ISI][Medline] [Order article via Infotrieve]



The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
J. R. Delanghe, A. Helander, J. P.M. Wielders, J. M. Pekelharing, H. J. Roth, F. Schellenberg, C. Born, E. Yagmur, W. Gentzer, and H. Althaus
Development and Multicenter Evaluation of the N Latex CDT Direct Immunonephelometric Assay for Serum Carbohydrate-Deficient Transferrin
Clin. Chem., June 1, 2007; 53(6): 1115 - 1121.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
H. A. Carchon, C. Nsibu Ndosimao, S. Van Aerschot, and J. Jaeken
Use of serum on guthrie cards in screening for congenital disorders of glycosylation.
Clin. Chem., April 1, 2006; 52(4): 774 - 775.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Helander, J. Bergstrom, and H. H. Freeze
Testing for Congenital Disorders of Glycosylation by HPLC Measurement of Serum Transferrin Glycoforms
Clin. Chem., May 1, 2004; 50(5): 954 - 958.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2003.021568v1
50/1/101    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carchon, H. A.
Right arrow Articles by Jaeken, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carchon, H. A.
Right arrow Articles by Jaeken, J.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Proteomics and Protein Markers
Right arrow Automation and Analytical Techniques

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS